Pennsylvania Convention Authority Renews ASM Global Management Contract Becoming First Venue in World Leader’s ‘Premier Package’ Convention Center Expansion
24.8.2023 23:46:00 EEST | Business Wire | Press release
The Pennsylvania Convention Center Authority (PCCA) board of directors has approved a five-year contract renewal for ASM Global as its venue management company with the convention center poised as the launch location for a dramatic series of innovations in ASM Global’s convention and conference portfolio — the largest in North America and worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230824372126/en/
Photo courtesy of ASM Global.
The new agreement will commence on Dec. 1, 2023, for five years, through Nov. 30, 2028, with the international entertainment leader planning to bring many of its most innovative designs to a leading group of convention centers beginning with PCCA. It will be the first in a program creating unique environments such as immersive LED moments, speed-action offerings to accelerate business strategies, elevated VIP lounges and quiet spaces for business connectivity.
“We are thrilled to announce the continued partnership between the Pennsylvania Convention Center Authority and ASM Global as the venue-management provider for the Pennsylvania Convention Center,” said David A. Nasatir, Esq., chair of the board, PCCA. “For 10 years, ASM Global has been a valued collaborator and, because of their outstanding contributions, has elevated the Pennsylvania Convention Center to world-class status.”
In 2013 the PCCA first made the decision to privatize management of the center with an initial contract being awarded to SMG, which was subsequently rebranded to ASM Global following the 2019 merger of AEG Facilities and SMG. The merger created a venue management powerhouse that spans five continents, 14 countries and more than 350 of the world’s most prestigious arenas, stadiums, theaters and convention centers and has positioned ASM Global as the world’s preeminent venue-management and live-experiences company.
“The ASM Global team at the Pennsylvania Convention Center is, without exception, the finest in the industry,” said John J. McNichol, president and CEO, PCCA. “Their innovative leadership and commitment to delivering an unmatched customer experience have positioned the center, globally, as an industry trailblazer and venue of choice, and we look forward to continuing our collaboration as we take the Pennsylvania Convention Center to the next level.”
Under the management of ASM Global, the Pennsylvania Convention Center has already implemented several cutting-edge and industry-changing initiatives such as the 2014 execution of the Customer Satisfaction Agreement, a document that guides the relationship between the center and the labor unions that work at the facility with the goal of providing a more productive, customer-centric and cost-effective worksite for guests and the ASM Global Acts program, under which the center has successfully executed a robust sustainability and social impact plan.
Dan Hoffend, ASM Global executive vice president, convention centers, said, “We’re excited to begin the next chapter for the convention universe beginning with the Pennsylvania Convention Center. This includes sustainability features that create substantial movement toward carbon neutral; new Flex-space exhibit halls that can adapt to the needs of our diverse attendees; and LED walls that provide sponsorship, wayfinding and entertainment.
“We’re bringing our proven best features from our stadiums and arenas directly to our convention centers to create a premium line of facilities like no other in the industry. Our attendees require entertainment as a part of their business paradigm. We are changing the industry by creating a unique environment for all of our guests,” Hoffend said.
PCC’s ASM Global general manager, Tony Hodgins, said, “We thank the PCCA for their continued trust in our ASM Global team and for their unwavering support over the years. Our team at the center remains focused on our goal of providing a first-class customer experience to all our guests, and we are honored to be able to continue working with our key partners to showcase all that Philadelphia and the Pennsylvania Convention Center have to offer.”
For more information on the Pennsylvania Convention Center community-engagement and outreach initiatives, visit paconvention.com.
About Pennsylvania Convention Center
Pennsylvania Convention Center is located in Center City Philadelphia at the heart of the city's many cultural offerings and world-class dining and entertainment scene. Managed by ASM Global, the center is the 14th largest facility in the nation and features one of the largest exhibit spaces and ballrooms in the Northeastern U.S. The meetings, conventions, trade shows and other events hosted by the center attract attendees from across the country and around the world to Philadelphia, making the facility the largest economic driver of the region’s hospitality industry. For more information, visit paconvention.com.
About ASM Global
ASM Global is the world’s leading producer of entertainment experiences. It is the global leader in venue and event strategy and management, delivering locally tailored solutions and cutting-edge technologies to achieve maximum results for venue owners. The company’s elite venue network spans five continents, with a portfolio of more than 350 of the world’s most prestigious arenas, stadiums, convention and exhibition centers, and performing arts venues. Follow us on Facebook, Instagram, LinkedIn and Twitter. For more information, please visit asmglobal.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230824372126/en/
Contact information
Jim Yeager
breakwhitelight (for ASM Global)
jim@breakwhitelight.com
818-264-6812
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
